• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微环境炎症浸润驱动肝细胞癌的生长速度和结局:一项前瞻性临床研究。

Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study.

机构信息

Department of Internal Medicine, Gastroenterology Unit, University of Modena and Reggio Emilia, Modena, Italy.

WomenInHepatology Network, Modena, Italy.

出版信息

Cell Death Dis. 2017 Aug 24;8(8):e3017. doi: 10.1038/cddis.2017.395.

DOI:10.1038/cddis.2017.395
PMID:28837142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5596578/
Abstract

In HCC, tumor microenvironment, heavily influenced by the underlying chronic liver disease, etiology and stage of the tissue damage, affects tumor progression and determines the high heterogeneity of the tumor. Aim of this study was to identify the circulating and tissue components of the microenvironment immune-mediated response affecting the aggressiveness and the ensuing clinical outcome. We analyzed the baseline paired HCC and the surrounding tissue biopsies from a prospective cohort of 132 patients at the first diagnosis of HCC for immunolocalization of PD-1/PD-L1, FoxP3, E-cadherin, CLEC2 and for a panel of 82 microRNA associated with regulation of angiogenesis, cell proliferation, cell signaling, immune control and autophagy. Original microarray data were also explored. Serum samples were analyzed for a panel of 19 cytokines. Data were associated with biochemical data, histopathology and survival. Patients with a more aggressive disease and shorter survival, who we named fast-growing accordingly to the tumor doubling time, at presentation had significantly higher AFP levels, TGF-β1 and Cyphra 21-1 levels. Transcriptomic analysis evidenced a significant downregulation of CLEC2 and upregulation of several metalloproteinases. A marked local upregulation of both PD-1 and PD-L1, a concomitant FoxP3-positive lymphocytic infiltrate, a loss of E-cadherin, gain of epithelial-mesenchymal transition (EMT) phenotype and extreme poor differentiation at histology were also present. Upregulated microRNA in fast-growing HCCs are associated with TGF-β signaling, angiogenesis and inflammation. Our data show that fast HCCs are characterized not only by redundant neo-angiogenesis but also by unique features of distinctively immunosuppressed microenvironment, prominent EMT, and clear-cut activation of TGFβ1 signaling in a general background of long-standing and permanent inflammatory state.

摘要

在 HCC 中,肿瘤微环境受潜在慢性肝病、病因和组织损伤阶段的严重影响,会影响肿瘤的进展并决定肿瘤的高度异质性。本研究旨在确定影响侵袭性和后续临床结果的免疫介导的微环境循环和组织成分。我们分析了 132 例 HCC 患者的前瞻性队列中基线配对的 HCC 和周围组织活检,对 PD-1/PD-L1、FoxP3、E-钙黏蛋白、CLEC2 进行免疫定位,并对与血管生成、细胞增殖、细胞信号转导、免疫控制和自噬调节相关的 82 个 microRNA 进行了分析。还探索了原始微阵列数据。分析了血清样本中与一组 19 种细胞因子相关的信息。数据与生化数据、组织病理学和生存情况相关联。表现出侵袭性更强和生存时间更短的患者,我们根据肿瘤倍增时间将其命名为快速生长型,他们的 AFP 水平、TGF-β1 和 Cyphra 21-1 水平显著更高。转录组分析表明 CLEC2 的表达显著下调,而几种金属蛋白酶的表达显著上调。局部 PD-1 和 PD-L1 的表达明显上调,伴有 FoxP3 阳性淋巴细胞浸润,E-钙黏蛋白丢失,上皮-间充质转化(EMT)表型获得,组织学上分化极差。快速生长型 HCC 中上调的 microRNA 与 TGF-β 信号、血管生成和炎症有关。我们的数据表明,快速生长的 HCC 不仅具有冗余的新生血管生成,而且具有独特的免疫抑制微环境特征,突出的 EMT,以及在长期和永久性炎症状态的普遍背景下明显激活 TGFβ1 信号。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/28ffec489959/cddis2017395f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/21231b4d6010/cddis2017395f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/cd2c8e1d184c/cddis2017395f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/8a9e5d503a2c/cddis2017395f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/705a649ff69b/cddis2017395f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/5e3c56f80814/cddis2017395f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/28ffec489959/cddis2017395f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/21231b4d6010/cddis2017395f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/cd2c8e1d184c/cddis2017395f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/8a9e5d503a2c/cddis2017395f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/705a649ff69b/cddis2017395f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/5e3c56f80814/cddis2017395f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62d6/5596578/28ffec489959/cddis2017395f6.jpg

相似文献

1
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study.微环境炎症浸润驱动肝细胞癌的生长速度和结局:一项前瞻性临床研究。
Cell Death Dis. 2017 Aug 24;8(8):e3017. doi: 10.1038/cddis.2017.395.
2
HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.在缺氧肿瘤微环境中,缺氧诱导因子-1α(HIF-1α)通过上调赖氨酰氧化酶样蛋白2(LOXL2)促进肝细胞癌中的血管生成拟态形成。
J Exp Clin Cancer Res. 2017 Apr 27;36(1):60. doi: 10.1186/s13046-017-0533-1.
3
MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.微小RNA-630通过TGF-β-微小RNA-630-Slug信号通路抑制肿瘤转移,且与肝细胞癌的不良预后呈负相关。
Oncotarget. 2016 Apr 19;7(16):22674-86. doi: 10.18632/oncotarget.8047.
4
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.肿瘤相关巨噬细胞通过转化生长因子-β1 诱导的上皮-间充质转化促进肝癌中的癌症干细胞样特性。
Cancer Lett. 2014 Oct 1;352(2):160-8. doi: 10.1016/j.canlet.2014.05.008. Epub 2014 Jun 2.
5
Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.调控 TGF-β1-CD147 自我维持网络在肝癌细胞分化可塑性中的作用。
Oncogene. 2016 Oct 20;35(42):5468-5479. doi: 10.1038/onc.2016.89. Epub 2016 Apr 4.
6
FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.FoxM1过表达促进肝细胞癌的上皮-间质转化和转移。
World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.
7
MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.微小RNA-122通过靶向Snail1和Snail2并抑制WNT/β-连环蛋白信号通路来抑制肝细胞癌中的上皮-间质转化。
Exp Cell Res. 2017 Nov 15;360(2):210-217. doi: 10.1016/j.yexcr.2017.09.010. Epub 2017 Sep 8.
8
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.新生血管生成相关基因是快速生长型肝细胞癌和最差生存的特征。一项前瞻性研究的结果。
Gut. 2016 May;65(5):861-9. doi: 10.1136/gutjnl-2014-308483. Epub 2015 Feb 9.
9
Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.趋化因子配体20通过上皮-间质转化促进肝细胞癌进展。
World J Gastroenterol. 2015 Jan 14;21(2):475-83. doi: 10.3748/wjg.v21.i2.475.
10
Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.不良基因组改变和干性特征由肝细胞癌微环境中的场癌化诱导产生。
Oncotarget. 2017 Jul 25;8(30):48688-48700. doi: 10.18632/oncotarget.16231.

引用本文的文献

1
EMT and cancer: what clinicians should know.上皮-间质转化与癌症:临床医生应了解的内容。
Nat Rev Clin Oncol. 2025 Jul 22. doi: 10.1038/s41571-025-01058-2.
2
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment.新生血管生成转录组特征影响肝细胞癌预后,且可由经动脉化疗栓塞治疗触发。
Cancers (Basel). 2024 Oct 21;16(20):3549. doi: 10.3390/cancers16203549.
3
Assessing microvascular invasion in HBV-related hepatocellular carcinoma: an online interactive nomogram integrating inflammatory markers, radiomics, and convolutional neural networks.

本文引用的文献

1
Circulating MicroRNAs as Novel Biomarkers of Stenosis Progression in Asymptomatic Carotid Stenosis.循环微小RNA作为无症状性颈动脉狭窄狭窄进展的新型生物标志物
Stroke. 2017 Jan;48(1):10-16. doi: 10.1161/STROKEAHA.116.013650. Epub 2016 Nov 29.
2
Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors.肺腺癌中PD-L1表达强度的评分及其与临床病理因素的相关性。
ESMO Open. 2016 Aug 26;1(4):e000083. doi: 10.1136/esmoopen-2016-000083. eCollection 2016.
3
MicroRNA-221-3p Plays an Oncogenic Role in Gastric Carcinoma by Inhibiting PTEN Expression.
评估乙型肝炎病毒相关肝细胞癌中的微血管侵犯:一种整合炎症标志物、放射组学和卷积神经网络的在线交互式列线图
Front Oncol. 2024 Sep 16;14:1401095. doi: 10.3389/fonc.2024.1401095. eCollection 2024.
4
Identification of Hub Genes in Liver Hepatocellular Carcinoma Based on Weighted Gene Co-expression Network Analysis.基于加权基因共表达网络分析的肝细胞癌关键基因鉴定
Biochem Genet. 2024 Apr 29. doi: 10.1007/s10528-024-10803-8.
5
The underlying mechanism and targeted therapy strategy of miRNAs cross-regulating EMT process through multiple signaling pathways in hepatocellular carcinoma.微小RNA通过多种信号通路交叉调控肝细胞癌上皮-间质转化过程的潜在机制及靶向治疗策略
Front Mol Biosci. 2024 Mar 22;11:1378386. doi: 10.3389/fmolb.2024.1378386. eCollection 2024.
6
C-type lectin-like receptor 2: roles and drug target.C型凝集素样受体2:作用及药物靶点
Thromb J. 2024 Mar 19;22(1):27. doi: 10.1186/s12959-024-00594-8.
7
Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence.解码免疫特征以检测早期肝癌复发风险。
Cancers (Basel). 2023 May 12;15(10):2729. doi: 10.3390/cancers15102729.
8
Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma.综合分析确定CLEC1B为肝细胞癌的潜在预后生物标志物。
Cancer Cell Int. 2023 Jun 12;23(1):113. doi: 10.1186/s12935-023-02939-1.
9
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma.雌激素靶基因SIX1的上调与丙型肝炎病毒阳性的肝细胞癌女性患者的较高生长速度和较低生存率相关。
Oncol Lett. 2022 Sep 21;24(5):395. doi: 10.3892/ol.2022.13515. eCollection 2022 Nov.
10
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation.移植肝中内皮血管生成素-2的过表达可识别肝移植后肝细胞癌复发风险较高的患者。
Front Oncol. 2022 Sep 8;12:960808. doi: 10.3389/fonc.2022.960808. eCollection 2022.
微小RNA-221-3p通过抑制PTEN表达在胃癌中发挥致癌作用。
Oncol Res. 2017 Apr 14;25(4):523-536. doi: 10.3727/096504016X14756282819385. Epub 2016 Oct 5.
4
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?PD-L1 生物标志物检测在非小细胞肺癌中的应用:是真是假?
J Immunother Cancer. 2016 Aug 16;4:48. doi: 10.1186/s40425-016-0153-x. eCollection 2016.
5
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features.程序性死亡配体 1 在肝细胞癌中的表达:与临床和病理特征的关系。
Hepatology. 2016 Dec;64(6):2038-2046. doi: 10.1002/hep.28710. Epub 2016 Aug 9.
6
miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma.miR-486-5p通过靶向结直肠癌中的神经纤毛蛋白-2来减弱肿瘤生长和淋巴管生成。
Onco Targets Ther. 2016 May 19;9:2865-71. doi: 10.2147/OTT.S103460. eCollection 2016.
7
EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.早期生长反应因子1(EGR1)介导微小RNA-203a(miR-203a)通过表皮生长因子受体(EGFR)信号通路靶向同源盒D3(HOXD3)抑制肝癌细胞进展。
Oncotarget. 2016 Jul 19;7(29):45302-45316. doi: 10.18632/oncotarget.9605.
8
Role of epithelial to mesenchymal transition in hepatocellular carcinoma.上皮间质转化在肝细胞癌中的作用。
J Hepatol. 2016 Oct;65(4):798-808. doi: 10.1016/j.jhep.2016.05.007. Epub 2016 May 17.
9
C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.C 型凝集素样受体 2 通过抑制磷酸肌醇 3-激酶亚基的表达来抑制胃癌细胞的 AKT 信号和侵袭活性。
Gastroenterology. 2016 May;150(5):1183-1195.e16. doi: 10.1053/j.gastro.2016.01.034. Epub 2016 Feb 6.
10
Biology of Hepatocellular Carcinoma.肝细胞癌生物学
Dig Dis. 2015 Sep;33(5):635-41. doi: 10.1159/000438472. Epub 2015 Sep 23.